Lunit

Conquer Cancer through AI. Lunit is a public company that develops medical AI software for cancer screening and treatment. Lunit AI can empower you to enhance diagnostic performance. Our AI for chest x-ray and 2D & 3D mammography has been validated through 100+ publications in peer-reviewed journals such as JAMA Oncology, Lancet Digital Health and Radiology, and is now in use in 3,500+ sites globally. < Lunit AI Suite for Radiology > • Lunit INSIGHT CXR, AI Solution for Chest X-ray • Lunit INSIGHT MMG, AI Solution for Mammography • Lunit INSIGHT DBT, AI Solution for Digital Breast Tomosynthesis • Lunit CXR Triage, AI solution for Chest X-ray Triage *emergency department use, available in the US only *If you are interested in Lunit Oncology, please visit Lunit Oncology’s LinkedIn page.

https://www.lunit.io

201-500 employees

Growth Trajectory

Lunit is poised for growth through continued product development of biomarker products and 3D breast screening solutions, further expansion into global markets and increased adoption by healthcare institutions, and ongoing partnerships with medical groups and technology companies. Their focus on AI-driven medical image analysis, biomarker prediction, and precision oncology positions them well to capitalize on industry trends.

Technical Challenges

Developing AI signatures from H&E to predict therapy response and resistance.

Integration with existing imaging systems (X-ray, mammography, CT) and laboratory equipment.

Ensuring seamless integration with hospital information systems (HIS) and electronic health records (EHR).

Compliance with medical device regulations (CE mark, FDA clearance, MFDS approval).

Meeting MDR CE Standards for 3D Breast Tomosynthesis AI Solution.

Tech Stack

AI algorithms for image analysisAI algorithms for image quantificationDeep LearningH&E slide analysisGenomicsMolecular characteristicsWebsitesCookiesAWSWorkable SoftwareFivecloud ITMile CorporationGoogle Cloud PlatformElasticsearchMongoDBMailgun TechnologiesHoneybadger IndustriesCloudAMQPHelloSignZendeskDeepgramAivenRedis Labs

Team Size

Radiology Group

Security Department

Corporate Affairs Group

Key Risks

Navigating evolving regulatory requirements for medical devices and AI-based diagnostics (FDA, CE, PMDA).

Maintaining a competitive edge in the rapidly evolving landscape of AI-powered medical imaging.

Ensuring data privacy and security compliance across diverse international markets.

Successfully integrating AI solutions into existing healthcare workflows and IT systems.

Opportunities

Expanding applications of AI algorithms for medical image analysis and biomarker prediction to new areas of oncology.

Forging new partnerships with medical groups, technology companies, and research institutions.

Leveraging AI to address market gaps in early cancer detection and prediction of immunotherapy response.

Capitalizing on geographic expansion opportunities in untapped markets.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats

Access Database

Updated every 5 minutes